We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9921:TWSEGiant Manufacturing Co., Ltd. Analysis

Data as of 2026-03-16 - not real-time

NT$74.80

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Giant Manufacturing is trading far beneath its discounted cash flow estimate, creating a clear valuation gap that suggests substantial upside. The company generates solid operating cash flow and free cash flow, while maintaining a modest dividend payout that appears sustainable given its cash position. Profitability metrics are weak, with margins near the low end of the industry, and trailing earnings are negative, but forward earnings estimates are positive, indicating a potential earnings turnaround. The balance sheet shows a sizable cash balance that exceeds the debt level, though leverage remains a consideration.
Technical indicators point to bearish momentum, as the MACD line sits below its signal and the histogram is negative. The RSI is in the lower portion of its range, hinting at oversold conditions that could precede a short‑term bounce. Volume is on an upward trend, providing support for a potential reversal. Moving averages are aligned in a downtrend, with the short‑term average below the mid‑term and long‑term averages. Overall market sentiment is extremely greedy, which may add speculative pressure to the stock.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • bearish MACD signaling continued downside pressure
  • RSI indicating oversold conditions that may limit further drops
  • proximity to a recent support level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant valuation upside versus discounted cash flow
  • positive forward earnings outlook
  • attractive dividend yield with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • structural growth potential in electric bicycles
  • sustainable dividend supported by strong cash generation
  • persistent undervaluation relative to intrinsic worth

Key Metrics & Analysis

Financial Health

Revenue Growth-24.90%
Profit Margin0.00%
P/E Ratio13.5
ROE0.39%
ROA0.18%
Debt/Equity39.93
P/B Ratio0.9
Op. Cash FlowNT$8.4B
Free Cash FlowNT$6.3B

Technical Analysis

TrendBearish
RSI34.6
SupportNT$70.80
ResistanceNT$91.50
MA 20NT$80.43
MA 50NT$87.43
MA 200NT$100.76
MACDBearish
VolumeIncreasing
Fear & Greed Index79.45

Valuation

Fair ValueNT$214.76
Target PriceNT$102.33
Upside/Downside36.81%
GradeUndervalued
TypeBlend
Dividend Yield2.94%

Risk Assessment

Beta0.63
Volatility33.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.